Nebbioso, Angela <br/><br/>
Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2011 
 - 2394-404 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-11-0525  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cells, Cultured<br/>Disulfides--pharmacology<br/>Down-Regulation--drug effects<br/>Epigenesis, Genetic--drug effects<br/>Female<br/>HCT116 Cells<br/>HL-60 Cells<br/>Humans<br/>K562 Cells<br/>Mice<br/>Mice, Nude<br/>Oximes--pharmacology<br/>Reactive Oxygen Species--metabolism<br/>Receptors, Death Domain--agonists<br/>Signal Transduction--drug effects<br/>U937 Cells<br/>Xenograft Model Antitumor Assays